Sexuality after breast cancer, how to provide a global and contemporary approach.


Journal

Bulletin du cancer
ISSN: 1769-6917
Titre abrégé: Bull Cancer
Pays: France
ID NLM: 0072416

Informations de publication

Date de publication:
Jan 2023
Historique:
received: 08 08 2022
revised: 01 10 2022
accepted: 04 10 2022
pubmed: 7 11 2022
medline: 14 1 2023
entrez: 6 11 2022
Statut: ppublish

Résumé

Patients' sexuality is one of the major and most neglected impact of breast cancer (BC) and its treatment. Even though research is ongoing on the subject, sexuality issues are rarely taken into account and efficiently dealt with in clinical practice. The objective is to review the impact of BC and its treatment on modern women sexuality. In the literature, a heterogeneous level of advancement is notable in the different publishing countries depending on the cultural background; some countries simply do not publish on the matter, others mainly discuss the male partners and practicians experience, and lastly, the most progressive countries have moved up to studying niches of patients such as sexual and gender minorities. A multidisciplinary approach, including pharmacologic and nonpharmacologic management, appears most efficient. There is a need for greater inclusion of partners and for providing a specific training to first-line health care providers. This review provides a general contemporary worldwide overview of the state of the art in sexuality issues in BC patients and survivors.

Identifiants

pubmed: 36336478
pii: S0007-4551(22)00396-4
doi: 10.1016/j.bulcan.2022.10.002
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

113-128

Informations de copyright

Copyright © 2022 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

Manon Mangiardi-Veltin (M)

PSL Research University, Institut Curie, Inserm U900, Saint-Cloud, France. Electronic address: manon.mangiardi@curie.fr.

Delphine Hequet (D)

PSL Research University, Institut Curie, Inserm U900, Saint-Cloud, France; PSL Research University, Institut Curie, Department of Surgery, Saint-Cloud, France.

Carine Segura-Djezzar (C)

Centre François-Baclesse, Department of Medical Oncology, Caen, France.

Roman Rouzier (R)

Centre François-Baclesse, Department of Surgery, Caen, France.

Claire Bonneau (C)

PSL Research University, Institut Curie, Inserm U900, Saint-Cloud, France; PSL Research University, Institut Curie, Department of Surgery, Saint-Cloud, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH